COVID-19: EMA Tackles Trial Data Interpretability

Sponsors Should Assess Likelihood Of Delivering Interpretable Results

 
• By Vibha Sharma
  
Young businessman working on a virtual screen of the future and sees the inscription: Clinical trial
EMA Will Be Pragmatic In Assessing Data From Trials Hit By Coronavirus • Source: Shutterstock

More from Clinical Trials

More from R&D